Stock Groups

U.S. CDC advisers to meet this month to discuss Moderna, J&J COVID-19 vaccine boosters By Reuters

© Reuters. FILE PHOTO A view from the Atlanta headquarters of Centers for Disease Control and Prevention, Georgia (September 30, 2014). REUTERS/Tami Chappell

(Reuters) – A panel of U.S. Centers for Disease Control and Prevention vaccine advisers is set to meet in October 20-21, to discuss COVID-19 vaccine boosters Moderna (NASDAQ:) and Johnson & Johnson (NYSE:) shots, an agency spokesperson said on Friday.

November 2-3, the CDC’s Advisory Committee on Immunization Practices, will be meeting to discuss COVID-19 immunization for children.

A spokesperson stated that the agendas of the meetings would be available closer to the dates.

Disclaimer Fusion MediaThis website does not provide accurate and current data. CFDs are stocks, indexes or futures. The prices of Forex and CFDs are not supplied by exchanges. They are instead provided by market makers. As such, the prices might not reflect market values and could be incorrect. Fusion Media does not accept any liability for trade losses you may incur due to the use of these data.

Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information. This includes data including charts and buy/sell signal signals. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.

Mike Robinson
Mike covers the financial, utilities and biotechnology sectors for Street Register. He has been writing about investment and personal finance topics for almost 12 years. Mike has an MBA in Finance from Wake Forest University.